The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Bychinin M.V.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Klypa T.V.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Mandel I.A.
Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies;
Sechenov First Moscow State Medical University (Sechenov University)
Korshunov D.I.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Kolyshkina N.A.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Dzheliev R.A.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Clinical and laboratory characteristics of intensive care patients of the first and second waves of the COVID-19 pandemic
Journal: Russian Journal of Anesthesiology and Reanimatology. 2022;(4): 57‑65
Views: 1381
Downloaded: 47
To cite this article:
Bychinin MV, Klypa TV, Mandel IA, Korshunov DI, Kolyshkina NA, Dzheliev RA. Clinical and laboratory characteristics of intensive care patients of the first and second waves of the COVID-19 pandemic. Russian Journal of Anesthesiology and Reanimatology.
2022;(4):57‑65. (In Russ.)
https://doi.org/10.17116/anaesthesiology202204157
The COVID-19 pandemic is characterized by an undulating course and changes in treatment approaches. Analysis of clinical and laboratory data and their changes will allow a more detailed investigation of characteristics of these patients.
To compare clinical and laboratory data of ICU patients of the first and second waves of the COVID-19 pandemic.
Clinical and laboratory data of 543 ICU patients in the first and second waves of the pandemic are presented.
Patients were older in the second wave (74 [64; 82] and 68 [57; 79] years, p=0.001). They also admitted to ICU later from the onset of disease and hospitalization compared to the first wave (10 [7; 13] and 11 [9; 17] days, 2.5 [0; 5] and 4 [2; 8] days, respectively). Mechanical ventilation time was shorter in the 2nd wave (10 [5; 15] and 4 [1; 7] hours). The use of haloperidol (29.5% and 38.8%) and glucocorticosteroids (23% and 88.9%) was more common in the second wave. Hemodialysis was more common in the first wave (17.5% and 8.4%). There were significant between-group differences in WBC count (p=0.001), platelet count (p=0.025), neutrophil-lymphocyte ratio (p=0.001), creatinine (p=0.043), C-reactive protein (p=0.001), procalcitonin (p=0.001). In the second wave, the length of ICU-stay was shorter (8 [4; 15] and 6 [3; 10] days, p=0.003), and mortality was higher (101 (50.5%) and 215 (62.7%), p=0.006).
Duration of outpatient and inpatient treatment has increased and resulted later admission of patients to ICU. Approaches to respiratory and drug therapy have changed. Mean age of patients was significantly higher in the second wave resulting appropriate increase of mortality with every decade.
Authors:
Bychinin M.V.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Klypa T.V.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Mandel I.A.
Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies;
Sechenov First Moscow State Medical University (Sechenov University)
Korshunov D.I.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Kolyshkina N.A.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Dzheliev R.A.
Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies
Received:
27.01.2022
Accepted:
22.04.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.